A detailed history of Hoese & CO LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Hoese & CO LLP holds 65 shares of LLY stock, worth $48,620. This represents 0.05% of its overall portfolio holdings.

Number of Shares
65
Previous 65 -0.0%
Holding current value
$48,620
Previous $58,000 1.72%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

BUY
$724.87 - $909.04 $10,873 - $13,635
15 Added 30.0%
65 $58,000
Q4 2021

Jan 18, 2022

BUY
$224.85 - $279.04 $11,242 - $13,952
50 New
50 $14,000
Q2 2021

Jul 13, 2021

SELL
$180.55 - $233.54 $43,332 - $56,049
-240 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $31,310 - $41,431
240 New
240 $41,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hoese & CO LLP Portfolio

Follow Hoese & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoese & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Hoese & CO LLP with notifications on news.